Lucy Xiaolu Wang

Lucy Xiaolu Wang is an Assistant Professor at the University of Massachusetts Amherst and an Affiliated Research Fellow at the Max Planck Institute for Innovation and Competition. Her work bridges health economics, innovation policy, and digitalization with practical applications in pharmaceutical markets, health information technology, and public finance.

• Education:
• Ph.D. in Economics (2020), Cornell University
• M.A. in Economics (2014), Duke University
• B.A. in Economics (2012), Central University of Finance and Economics

Her research examines how regulatory frameworks shape healthcare innovation and market behavior. Key studies include analyzing pharmaceutical patent strategies post-marketing authorization, evaluating pooled drug procurement mechanisms in developing countries, and investigating health IT integration in opioid monitoring systems. Recent work explores cannabis legalization effects on medical innovation and digital health infrastructure development.

Her scientific awards include:

• Best Paper Awards (Wharton, EPIP, Academy of Management)
• Multiple travel and research fellowships (Cornell, Duke, George Mason)
• National-level scholarships and competitions (China Ping An, Insurance Society of China)

Wang's policy contributions address critical issues in global drug access, prescription transparency, and technology-driven healthcare solutions. Her empirical work leverages novel datasets spanning clinical trials, licensing contracts, and federal procurement programs.